Nanjing Kangchuanji Pharmaceutical Technology

Nanjing Kangchuanji Pharmaceutical Technology is a specialized pharmaceutical R&D company focused on high-end formulation development and complex drug delivery systems. Based in Nanjing, China, the company operates as both a CRO/CDMO and a developer of improved new drugs (Class 2.2) using its proprietary technology platforms for microspheres, liposomes, and nanocrystals. Their service offerings encompass the entire drug development lifecycle, from pharmaceutical analysis and formulation optimization to clinical trial management. Kangchuanji's internal pipeline primarily targets central nervous system disorders, oncology, and metabolic diseases through long-acting injectable formulations. The company aims to bridge the gap between innovative drug discovery and clinical application by enhancing the delivery profiles of established therapeutic agents.